Attenuation of cardiac dysfunction by a PPAR-α agonist is associated with down-regulation of redox-regulated transcription factors-Reference-Cited by-同舟云学术

Attenuation of cardiac dysfunction by a PPAR-α agonist is associated with down-regulation of redox-regulated transcription factors

Published:2006-08 Issue:2 Volume:41 Page:318-329
ISSN:0022-2828
Container-title:Journal of Molecular and Cellular Cardiology
language:en
Short-container-title:Journal of Molecular and Cellular Cardiology

Author:

Ichihara Sahoko,Obata Koji,Yamada Yoshiji,Nagata Kohzo,Noda Akiko,Ichihara Gaku,Yamada Akira,Kato Tomoko,Izawa Hideo,Murohara Toyoaki,Yokota Mitsuhiro

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Molecular Biology

Reference41 articles.

1. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective;Alexander;Hypertension,1995

2. Role of oxidative stress in transition of hypertrophy to heart failure;Dhalla;J Am Coll Cardiol,1996

3. Stress pathways and heart failure;Chien;Cell,1999

4. Antioxidant and redox regulation of gene transcription;Sen;FASEB J,1996

5. Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure;Frantz;Cardiovasc Res,2003

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pleiotropic Effects of Peroxisome Proliferator-Activated Receptor Alpha and Gamma Agonists on Myocardial Damage: Molecular Mechanisms and Clinical Evidence—A Narrative Review;Cells;2024-09-05

2. Long Noncoding RNA MALAT1: Salt-Sensitive Hypertension;International Journal of Molecular Sciences;2024-05-18

3. Identification of ferroptosis-related diagnostic biomarkers in ischemic cardiomyopathy Abstract;2023-03-07

4. Identification of shared fatty acid metabolism related signatures in dilated cardiomyopathy and myocardial infarction;Future Science OA;2023-03

5. Therapeutic inhibition of PPARα-HIF1α-PGK1 signaling targets leukemia stem and progenitor cells in acute myeloid leukemia;Cancer Letters;2023-02